Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.29%58.81B | -11.68%35.47B | -12.09%17.6B | -8.31%88B | -4.62%66.3B | -3.75%40.16B | 13.45%20.02B | 19.68%95.98B | 14.16%69.51B | 16.16%41.73B |
| Operating revenue | -11.29%58.81B | -11.68%35.47B | -12.09%17.6B | -8.31%88B | -4.62%66.3B | -3.75%40.16B | 13.45%20.02B | 19.68%95.98B | 14.16%69.51B | 16.16%41.73B |
| Other operating revenue | ---- | -24.49%2.15B | ---- | -38.69%5.72B | ---- | 13.64%2.85B | ---- | 8.70%9.34B | ---- | -38.73%2.51B |
| Interest income | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Commission income | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Premiums earned | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total operating cost | -11.79%54.11B | -11.23%33.61B | -9.80%17.3B | -10.49%81.79B | -6.19%61.34B | -7.38%37.86B | 8.41%19.18B | 5.18%91.38B | 2.11%65.38B | 6.87%40.88B |
| Operating cost | -11.85%51.15B | -11.50%31.63B | -9.90%16.36B | -11.11%77.3B | -6.90%58.03B | -8.47%35.74B | 7.50%18.15B | 4.32%86.97B | 1.16%62.33B | 6.51%39.05B |
| Operating tax surcharges | 12.66%390.76M | 13.80%235.4M | -0.42%108.95M | 19.84%498.29M | 30.48%346.84M | 23.94%206.85M | 71.95%109.41M | 25.84%415.78M | 12.32%265.81M | 3.39%166.9M |
| Operating expense | -25.93%109.73M | -15.53%77.66M | -33.85%32.86M | 25.19%206.1M | -6.66%148.15M | 88.08%91.94M | 339.07%49.67M | --164.63M | --158.72M | --48.88M |
| Administration expense | -7.86%1.51B | 1.14%1.04B | 3.76%489.92M | 6.25%2.19B | 18.23%1.64B | 18.20%1.03B | 25.78%472.16M | 24.92%2.06B | 27.14%1.39B | 19.73%869.08M |
| Financial expense | -12.83%745.22M | -20.32%474.41M | -23.12%243.02M | -12.78%1.08B | -7.95%854.87M | 1.89%595.38M | 5.46%316.08M | -2.82%1.24B | -4.93%928.73M | -8.60%584.31M |
| -Interest expense (Financial expense) | -8.32%948.5M | -11.78%626.91M | -15.24%310.73M | -10.72%1.38B | -10.61%1.03B | -4.45%710.59M | 7.72%366.6M | 10.86%1.55B | 10.71%1.16B | 9.30%743.68M |
| -Interest Income (Financial expense) | 27.36%-171.28M | 33.09%-111.33M | 35.38%-50.98M | -5.04%-323.24M | -20.63%-235.78M | -40.66%-166.4M | -79.19%-78.89M | -109.06%-307.72M | -154.11%-195.45M | -127.37%-118.29M |
| Research and development | -37.34%199.01M | -23.72%148.79M | -12.80%65.87M | -3.88%514.99M | 2.91%317.6M | 22.39%195.07M | 44.73%75.54M | 105.13%535.76M | 184.52%308.63M | 162.11%159.38M |
| Credit Impairment Loss | 292.89%32.31M | 240.40%32.54M | 26.03%-2.82M | 51.36%-79.45M | 88.99%-16.75M | 64.19%-23.18M | -242.63%-3.82M | -408.11%-163.33M | -1,499.32%-152.1M | -635.99%-64.72M |
| Asset Impairment Loss | 94.27%-17.96M | 98.76%-4.41M | -39.59%-19.58M | -182.50%-1.22B | -325.58%-313.12M | -1,786.15%-356.98M | -498.82%-14.02M | -217.11%-433.32M | -33,247.95%-73.58M | -8,880.84%-18.93M |
| Other net revenue | -20.44%3.3B | -20.43%2.31B | -25.62%1.04B | -15.99%3.95B | -0.58%4.14B | 7.14%2.9B | 9.88%1.4B | 34.30%4.71B | 30.40%4.17B | 13.11%2.71B |
| Fair value change income | -139.99%-1.31M | -128.61%-1.78M | -118.87%-1.2M | 322.53%149.47M | 107.91%3.28M | 111.79%6.22M | 146.99%6.34M | -6,248.78%-67.17M | -490.69%-41.49M | -2,037.79%-52.77M |
| Invest income | -21.39%2.96B | -20.44%2.08B | -26.74%902.55M | -10.06%4.15B | -3.86%3.76B | 3.66%2.61B | 22.47%1.23B | 39.91%4.61B | 35.66%3.91B | 19.67%2.52B |
| -Including: Investment income associates | -24.05%2.58B | -23.86%1.71B | -31.56%840.92M | -11.09%3.77B | -4.03%3.4B | 3.43%2.25B | 20.48%1.23B | 44.96%4.24B | 39.95%3.55B | 23.26%2.18B |
| Asset deal income | -76.47%99.14M | -99.62%1.59M | 30,066.43%10.01M | 99.97%642.38M | 103.29%421.26M | 530.60%420.58M | -99.94%33.18K | 1,075.26%321.24M | 5,076.88%207.22M | 8,662.27%66.69M |
| Other revenue | -20.84%228.71M | -16.49%202.69M | -14.88%149.58M | -27.27%319.77M | -8.83%288.93M | -5.91%242.71M | -20.99%175.73M | 24.78%439.67M | 2.69%316.91M | -12.28%257.97M |
| Operating profit | -12.08%8B | -19.85%4.17B | -40.15%1.34B | 9.28%10.17B | 9.78%9.1B | 46.29%5.21B | 82.34%2.24B | 392.87%9.3B | 17,424.53%8.29B | 5,125.85%3.56B |
| Add:Non operating Income | 364.75%107.25M | 859.87%103.83M | 621.86%45.6M | 327.60%126.81M | -71.48%23.08M | 27.02%10.82M | 89.98%6.32M | -80.39%29.66M | 775.58%80.92M | 98.77%8.52M |
| Less:Non operating expense | -43.50%107.58M | -81.29%30.2M | -80.93%20.44M | 15.53%262.51M | 100.40%190.42M | 353.12%161.42M | 426.18%107.19M | 212.35%227.22M | 83.65%95.02M | 53.50%35.62M |
| Total profit | -10.44%8B | -16.01%4.25B | -36.15%1.37B | 10.16%10.03B | 7.94%8.94B | 43.15%5.06B | 76.58%2.14B | 393.91%9.11B | 171,532.28%8.28B | 7,081.01%3.53B |
| Less:Income tax cost | -0.25%968.79M | -34.41%401.85M | -13.25%174.34M | -5.26%1.14B | -13.54%971.17M | 33.36%612.64M | 32.66%200.96M | 138.25%1.2B | 162.53%1.12B | 149.59%459.4M |
| Net profit | -11.69%7.03B | -13.47%3.85B | -38.53%1.19B | 12.51%8.89B | 11.31%7.96B | 44.61%4.44B | 82.85%1.94B | 319.30%7.9B | 1,791.46%7.16B | 2,378.61%3.07B |
| Net profit from continuing operation | -11.69%7.03B | -13.47%3.85B | -38.53%1.19B | 12.51%8.89B | 11.31%7.96B | 44.61%4.44B | 82.85%1.94B | 319.30%7.9B | 1,791.46%7.16B | 2,378.61%3.07B |
| Less:Minority Profit | -36.63%804.3M | -35.50%333.51M | -5.52%118.48M | -17.70%1.14B | 6.41%1.27B | 75.57%517.1M | 147.11%125.4M | 177.86%1.38B | 236.21%1.19B | 155.55%294.53M |
| Net profit of parent company owners | -6.96%6.23B | -10.57%3.51B | -40.81%1.07B | 18.92%7.75B | 12.29%6.7B | 41.33%3.93B | 79.62%1.82B | 456.83%6.52B | 1,217.33%5.96B | 602.81%2.78B |
| Earning per share | ||||||||||
| Basic earning per share | -8.00%0.46 | -10.34%0.26 | -42.86%0.08 | 18.37%0.58 | 13.64%0.5 | 38.10%0.29 | 75.00%0.14 | 450.00%0.49 | 1,366.67%0.44 | 600.00%0.21 |
| Diluted earning per share | -8.00%0.46 | -10.34%0.26 | -42.86%0.08 | 18.37%0.58 | 13.64%0.5 | 38.10%0.29 | 75.00%0.14 | 450.00%0.49 | 1,366.67%0.44 | 600.00%0.21 |
| Other composite income | -115.54%-161.01M | 30.53%602.1M | 9.30%297.85M | 439.63%1.18B | 1,107.10%1.04B | 243.68%461.28M | 333.43%272.51M | 40.44%-346.91M | 87.97%-102.88M | -17.68%-321.04M |
| Other composite income of parent company owners | -114.34%-148.07M | 35.21%614.32M | 12.80%297.87M | 451.77%1.18B | 1,115.58%1.03B | 243.25%454.33M | 320.41%264.07M | 42.36%-335.85M | 88.12%-101.66M | -16.32%-317.17M |
| Other composite income of minority owners | -454.14%-12.94M | -275.85%-12.22M | -100.20%-16.74K | 71.01%-3.21M | 399.66%3.65M | 279.43%6.95M | 174.55%8.43M | -9,530.38%-11.06M | -1,036.94%-1.22M | -2,624.86%-3.87M |
| Total composite income | -23.64%6.87B | -9.33%4.45B | -32.64%1.49B | 33.27%10.07B | 27.63%9B | 78.24%4.91B | 134.76%2.21B | 280.50%7.56B | 651.58%7.05B | 775.05%2.75B |
| Total composite income of parent company owners | -21.30%6.08B | -5.82%4.13B | -34.00%1.37B | 44.48%8.93B | 31.86%7.73B | 78.00%4.38B | 133.48%2.08B | 356.62%6.18B | 1,554.93%5.86B | 1,906.38%2.46B |
| Total composite income of minority owners | -37.83%791.35M | -38.69%321.3M | -11.48%118.47M | -17.27%1.14B | 6.83%1.27B | 80.30%524.05M | 156.56%133.83M | 177.24%1.37B | 236.05%1.19B | 154.80%290.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.